Placing STI cartridge into POC Desktop Instrument

binx health Announces First Patients Benefiting from Single-Visit Test and Treatment for Chlamydia and Gonorrhea

binx FDA-cleared platform already impacting human health—poised to transform care for millions


binx health Receives FDA 510(k) Clearance for Rapid Point of Care Platform for Women’s Health

binx io enables first-ever “test-and-treat” paradigm with sample to answer in 30 minutes for the two most tested-for sexually transmitted infections (STIs)


binx health Targeting Broader STI Screening With Rapid POC Platform

Aiming to drive greater adoption of tests for sexually transmitted diseases, binx health believes it is well placed to benefit from an expansion of services at US health clinics with…


binx health Receives CE Mark for Rapid Chlamydia and Gonorrhea Test for Mass Markets

Multiplex Test Panel for binx io® Point-of-Care Platform. Positioned to Radically Reduce Time to Treatment, Expand Access to Care


Healthcare Executive from Amazon Joins binx health’s Board of Directors

binx health, a pioneer in convenient health, today announced that it has appointed Samar Parikh to its Board of Directors.

binx blog

Top Factors That Increase the Risk of Getting an STI

Looking for convenient, discreet, at-home STI Testing? Take our simple quiz to find the right test for you. Anyone who’s sexually active has the risk of getting an STD/STI (sexually…


binx health’s Rapid, Point-of-Care Platform Shows Clinical Strength for Chlamydia Testing in Study by Johns Hopkins University and National Institutes of Health

Study reports 93% sensitivity and 99% specificity in 30-minute desktop instrument


Atlas Genetics Announces Company Rebranding, Changes Name to binx health

Atlas Genetics, a pioneer in near-patient testing solutions, has been renamed binx health, and has aligned with additional healthcare pioneers as it redefines new categories of convenient testing where people…